Teva's Deal-Making Spurs Inflows To Israel ETFs By: Benzinga via Benzinga August 03, 2015 at 10:25 AM EDT Israel-based Teva Pharmaceuticals (NASDAQ: TEVA) last week said it will pay $40.5 billion for Allergan(NYSE: AGN)'s generic ... Read More >> Related Stocks: Israel Ishares MSCI ETF Teva Pharmaceutical Industries ADR